Structure of COX-1 and COX-2 enzymes and their interaction with inhibitors

Drugs of Today

Volumn 35, Issue 4-5, 1999, Pages 237-250

  Bakhle, Y S ^a  

^a NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

5 (4 FLUOROPHENYL) 1 [(4 METHYLSULFONYL)PHENYL] 3 TRIFLUOROMETHYLPYRAZOLE; 5 BROMO 2 (4 FLUOROPHENYL) 3 (4 METHYLSULFONYLPHENYL)THIOPHENE; 6 (2,4 DIFLUOROPHENYLTHIO) 5 METHANESULFONAMIDO 1 INDANONE; CELECOXIB; CYCLOOXYGENASE 1; CYCLOOXYGENASE 1 INHIBITOR; CYCLOOXYGENASE 2; CYCLOOXYGENASE 2 INHIBITOR; IBUPROFEN; INDOMETACIN; N (2 CYCLOHEXYLOXY 4 NITROPHENYL)METHANESULFONAMIDE; NIMESULIDE; RS 5706700; SULFONAMIDE; SULFONE; UNCLASSIFIED DRUG;

ANTIINFLAMMATORY ACTIVITY; BINDING SITE; CONFERENCE PAPER; ENZYME ACTIVE SITE; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME LOCALIZATION; ENZYME STRUCTURE; ENZYME SUBSTRATE COMPLEX; GENE SEQUENCE; PROSTAGLANDIN SYNTHESIS;

EID: 0032788120     PISSN: 16993993     EISSN: 16994019     Source Type: Journal    
DOI: 10.1358/dot.1999.35.4-5.552200     Document Type: Conference Paper

References (70)

1. Otto, J.C., Smith, W.L. Prostaglandin endoperoxide synthases-1 and -2. J Lipid Mediat Cell Signalling 1995, 12: 139-56.
2. Herschman, H.R. Prostaglandin synthase 2. Biochem Biophys Acta 1996, 1299: 125-40.
3. Bakhle, Y.S., Botting, R.M. Cyclooxygenase-2 and its regulation in inflammation. Med Inflamm 1996, 5: 305-23.
4. Griswold, D.E., Adams, J.L. Constitutive cyclooxygenase (COX-1) and inducible cyclooxygenase (COX-2): rationale for selective inhibition and progress to date. Med Res Rev 1996, 16: 181-206.
5. Jouzeau, J.-Y., Terlain, B., Abid, A., Nedelec, E., Netter, P. Cyclooxygenase isoenzymes. How recent findings affect thinking about non-steroidal anti-inflammatory drugs. Drugs 1997, 53: 563-82.
6. 2) gene to 1q25 by fluorescence in situ hybridization. Genomics 1994, 23: 718-9.
7. Tazawa, R., Xu, X.M., Wu, K.K., Wang, L.H. Characterization of the genomic structure, chromosomal location and promoter of human prostaglandin H synthase-2 gene. Biochem Biophys Res Commun 1994, 203: 190-9.
8. 2) encoding prostaglandin-endoperoxide synthase 2. Eur J Biochem 1994, 221: 889-97.
9. Xie, W., Merrill, J.R., Bradshaw, W.S., Simmons, D.L. Structural determination and promoter analysis of the chicken mitogen-inducible prostaglandin G/H synthase gene and genetic mapping of the murine homolog. Arch Biochem Biophys 1993, 300: 247-52.
10. 2 genes in embryonic mouse cells. J Biol Chem 1994, 269: 21786-92.
11. Appleby, S.B., Ristimaki, A., Neilson, K., Narko, K., Hla, T. Structure of the human cyclooxygenase-2 gene. Biochem J 1994, 302: 723-7.
12. Inoue, H., Nanayama, T., Hara, S., Yokoyama, C., Tanabe, T. The cyclic AMP response element plays an essential role in the expression of the human prostaglandin-endoperoxide synthase 2 gene in differentiated U937 monocytic cells. FEBS Lett 1994, 350: 51-4.
13. Inoue, H., Yokoyama, C., Hara, S., Tone, Y., Tanabe, T. Translational regulation of human prostaglandin-endoperoxide synthase-2 gene by lipopolysaccharide and phorbol ester in vascular endothelial cells. J Biol Chem 1995, 270: 24965-71.
14. Feng, L., Sun, W., Xia, Y. et al. Cloning two isoforms of rat cyclooxygenase: Differential regulation of their expression. Arch Biochem Biophys 1993, 307: 361-8.
15. Ristimaki, A., Garfinkel, S., Wessendorf, J., Maciag, T., Hla, T. Induction of cyclooxygenase-2 by interleukin-1α. Evidence for posttranscriptional regulation. J Biol Chem 1994, 269: 11769-75.
16. Hamasaki, Y., Kitzler, J., Hardman, R., Nettesheim, P., Eling, T.E. Phorbol ester and epidermal growth factor enhance the expression of two inducible prostaglandin H synthase genes in rat tracheal epithelial cells. Arch Biochem Biophys 1993, 304: 226-34.
17. Shaw, G., Kamen, R. A conserved AU sequence from the 3'-untranslated region of GM-CSF mRNA mediates selective mRNA degradation. Cell 1986, 46: 659-67.
18. Luong, C., Miller, A., Barnett, J., Chow, J., Ramesha, C., Browner, M.F. Flexibility of the NSAID binding site in the structure of human cyclooxygenase-2. Nat Struct Biol 1996, 3: 927-33.
19. Kurumbail, R.G., Stevens, A.M., Gierse, J.K., et al. Structural basis for selective inhibition of cyclooxygenase-2 by anti-inflammatory agents. Nature 1996, 384: 644-8.
20. Guo, Q., Chang, S., Diekman, L., Xiao, G., Kulmacz, R.J. Comparison of prostaglandin H synthase isoform structures using limited proteolytic digestion. Arch Biochem Biophys 1997, 344: 150-8.
21. Wong, E., Bayly, C., Waterman, H.L., Riendeau, D., Mancini, J.A. Conversion of prostaglandin G/H synthase-1 into an enzyme sensitive to PGHS-2-selective inhibitors by a double His513 to Arg and lle523 to Val mutation. J Biol Chem 1997, 272: 9280-6.
22. 2 synthase-1. Nature 1994, 367: 243-9.
23. Lecomte, M., Laneuville, O., Ji, C., DeWitt, D.L., Smith, W.L. Acetylation of human prostaglandin endoperoxide synthase-2 (cyclooxygenase-2) by aspirin. J Biol Chem 1994, 269: 13207-15.
24. Tsai, A., Hsi, L.C., Kulmacz, R.J., Palmer, G., Smith, W.L. Characterization of the tyrosyl radicals in ovine prostaglandin H synthase-1 by isotope replacement and site-directed mutagenesis. J Biol Chem 1994, 269: 5085-91.
25. Kulmacz, R.J., Pendleton, R.B., Lands, W.E. Interaction between peroxidase and cyclooxygenase activities in prostaglandin-endoperoxide synthase. Interpretation of reaction kinetics. J Biol Chem 1994, 269: 5527-36.
26. Picot, D., Garavito, R.M. Prostaglandin H synthase: Implications for membrane structure. FEBS Lett 1994, 346: 21-5.
27. Mancini, J.A., O'Neill, G.P., Bayly, C., Vickers, P.J. Mutation of serine-516 in human prostaglandin G/H synthase-2 to methionine or aspirin acetylation of this residue stimulates 15-R-HETE synthesis. FEBS Lett 1994, 342: 33-7.
28. O'Neill, G.P., Mancini, J.A., Kargman, S., et al. Overexpression of human prostaglandin G/H synthase-1 and -2 by recombinant vaccinia virus: inhibition by nonsteroidal anti-inflammatory drugs and biosynthesis of 15-hydroxye-icosatetraenoic acid. Mol Pharmacol 1994, 45: 245-54.
29. 2 synthase. Nat Struct Biol 1995, 2: 637-43.
30. Mancini, J.A., Riendeau, D., Falgueyret, J.P., Vickers, P.J., O'Neill, G.P. Arginine 120 of prostaglandin G/H synthase-1 is required for the inhibition by nonsteroidal anti-inflammatory drugs containing a carboxylic acid moiety. J Biol Chem 1995, 270: 29372-7.
31. Bhattacharyya, D.K., Lecomte, M., Rieke, C.J., Garavito, R.M., Smith, W.L. Involvement of Arginine 120, Glutamate 524 and Tyrosine 355 in the binding of arachidonate and 2-phenyl-propionic acid inhibitors to the cyclooxygenase active site of ovine prostaglandin endoperoxide H synthase-1. J Biol Chem 1996, 271: 2179-84.
32. Gierse, J.K., McDonald, J.J., Hauser, S.D., Rangwala, S.H., Koboldt, C.M., Seibert, K. A single amino acid difference between cyclooxygenase-1 (COX-1) and -2 (COX-2) reverses the selectivity of COX-2 specific inhibitors. J Biol Chem 1996, 271: 15810-4.
33. Guo, Q., Wang, L., Ruan, K., Kulmacz, R.J. Role of Val509 in time-dependent inhibition of human prostaglandin H synthase-2 cyclooxygenase activity by isoform-selective agents. J Biol Chem 1996, 271: 19134-9.
34. Copeland, R.A., Williams, J.M., Giannaras, J., et al. Mechanism of selective inhibition of the inducible isoform of prostaglandin G/H synthase. Proc Natl Acad Sci USA 1994, 91: 11202-6.
35. Quellet, M., Percival, M.D. Effect of inhibitor time-dependency on selectivity towards cyclooxygenase isoforms. Biochem J 1995, 306: 247-51.
36. Klein, T., Nusing, R.M., Wiesenberg-Boettcher, I., Ullrich, V. Mechanistic studies on the selective inhibition of cyclooxygenase-2 by indanone derivatives. Biochem Pharmacol 1996, 51: 285-90.
37. Gierse, J.K., Hauser, S.D., Creely, D.P. et al. Expression and selective inhibition of the constitutive and inducible forms of human cyclooxygenase. Biochem J 1995, 305: 479-84.
38. Hsi, L.C., Hoganson, C.W., Babcock, G.T., Garavito, R.M., Smith, W.L. An examination of the source of the tyrosyl radical in ovine prostaglandin endoperoxide synthase-1. Biochem Biophys Res Commun 1995, 207: 652-60.
39. Loll, P.J., Garavito, R.M. The isoforms of cyclooxygenase: Structure and function. Exp Opin Invest Drugs 1994, 3: 1171-80.
40. Seibert, K., Zhang, Y., Leahy, K. et al. Pharmacological and biochemical demonstration of the role of cyclooxygenase 2 in inflammation and pain. Proc Natl Acad Sci USA 1994, 91: 12013-7.
41. Penning, T.D., Talley, J.J., Bertenshaw, S.R. et al. Synthesis and biological evaluation of the 1,5-diarylpyrazole class of cyclooxygenase-2 inhibitors: Identification of 4-[5-(4-methyl-phenyl)-3-(tri-fluoromethyl)-1H-pyrazol-1-yl]-benzenesulfonamide (SC-58635, celecoxib). J Med Chem 1997, 40: 1347-65.
42. Chan, C.-C., Boyce, S., Brideau, C. et al. Pharmacology of a selective cyclooxygenase-2 inhibitor, L-745,337: A novel nonsteroidal anti-inflammatory agent with an ulcerogenic sparing effect in rat and non-human primate stomach. J Pharmacol Exp Ther 1995, 274: 1531-7.
43. Riendeau, D., Percival, M.D., Boyce, S. et al. Biochemical and pharmacological profile of a tetrasubstituted furanone as a highly selective COX-2 inhibitor. Br J Pharmacol 1997, 121: 105-17.
44. Smith, W.L., Lands, W.E. Oxygenation of polyunsaturated fatty acids during prostaglandin biosynthesis by sheep vesicular gland. Biochemistry 1972, 11: 3276-85.
45. Bakovic, M., Dunford, H.B. Pre-steady-state kinetics and modelling of the oxygenase and cyclooxygenase reactions of prostaglandin endoperoxide synthase. Biophys Chem 1995, 54: 237-51.
46. 2 synthase are markedly affected by glutathione and glutathione peroxidase(s). Biochemistry 1995, 34: 3325-37.
47. Kulmacz, R.J., Wang, L.-H. Comparison of hydroperoxide initiator requirements for the cyclooxygenase activities of prostaglandin H synthase-1 and -2. J Biol Chem 1995, 270: 24019-23.
48. 2 synthase II catalysis of arachidonic acid to 15-HETE. Biochemistry 1997, 36: 7527-34.
49. Hemler, M.E., Lands, W.E. Evidence for a peroxide-initiated free radical mechanism of prostaglandin biosynthesis. J Biol Chem 1980, 255: 6253-61.
50. Calzada, C., Vericel, E., Lagarde, M. Low concentrations of lipid hydroperoxides prime human platelet aggregation specifically via cyclooxygenase activation. Biochem J 1997, 325: 495-500.
51. Song, Y., Connor, D.T., Sorenson, R.J. et al. 2,6-di-tert-butylphenols: A new class of potent and selective PGHS-2 inhibitor. Inflamm Res 1997, 46: S141-2.
52. Halliwell, B., Gutteridge, J.M.C. Free Radicals in Biology and Medicine. Clarendon Press: Oxford 1985.
53. Otto, J.C., Smith, W.L. The orientation of prostaglandin endoperoxide synthases-1 and -2 in the endoplasmic reticulum. J Biol Chem 1994, 269: 19868-75.
54. Regier, M.K., DeWitt, D.L., Schindler, M.S., Smith, W.L. Subcellular localization of prostaglandin endoperoxide synthase-2 in murine 373 cells. Arch Biochem Biophys 1993, 301: 439-44.
55. Morita, I., Schindler, M.S., Regier, M.K. et al. Different intracellular locations for prostaglandin endoperoxide H synthase-1 and -2. J Biol Chem 1995, 270: 10902-8.
56. Ren, Y., Walker, C., Loose-Mitchell, D.S., Deng, J., Ruan, K.-H., Kulmacz, R.J. Topology of prostaglandin H synthase-1 in the endoplasmic reticulum membrane. Arch Biochem Biophys 1995, 323: 205-14.
57. Pelham, H.R. The retention signal for soluble proteins of the endoplasmic reticulum. Trends Biochem Sci 1990, 15: 483-6.
58. Ren, Y., Loose-Mitchell, D.S., Kulmacz, R.J. Prostaglandin H synthase-1: Evaluation of C-terminus function. Arch Biochem Biophys 1995, 316: 751-7.
59. Kennedy, T.A., Smith, C.J., Marnett, L.J. Investigation of the role of cysteines in catalysis by prostaglandin endoperoxide synthase. J Biol Chem 1994, 269: 27357-64.
60. Mangelsdorf, D.J., Evans, R.M. The RXR heterodimers and orphan receptors. Cell 1995, 83: 841-50.
61. 2 metabolite binds peroxisome proliferator-activated receptor gamma and promotes adipocyte differentiation. Cell 1995, 83: 813-9.
62. 2 is a ligand for the adipocyte determination factor PPARγ. Cell 1995, 83: 803-12.
63. Yu, K., Bayona, W., Kallen, C.B. et al. Differential activation of peroxisome proliferator-activated receptors by eicosanoids. J Biol Chem 1995, 270: 23975-83.
64. 2. J Lipid Mediat Cell Signal 1995, 12: 443-8.
65. 2 and related compounds: An update. Prostaglan Leukot Essent Fatty Acids 1992, 47: 1-12.
66. Sasaki, H., Fukushima, M. Prostaglandins in the treatment of cancer. Anticancer Drugs 1994, 5: 131-8.
67. 2-induced expression of rat heme oxygenase-1 gene. FEBS Lett 1995, 372: 279-82.
68. 2-induced expression of the rat heme oxygenase gene. J Biol Chem 1996, 270: 21779-84.
69. Willis, D., Moore, A.R., Frederick, R., Willoughby, D.A. Heme oxygenase: A novel target for the modulation of the inflammatory response. Nat Med 1996, 2: 87-90.
70. Tsuji, M., Dubois, R.N. Alterations in cellular adhesion and apoptosis in epithelial cells overexpressing prostaglandin endoperoxide synthase 2. Cell 1995, 83: 493-501.